ARCHIVE

• SSP: Declines in Market Prices Hit Sales and Profits
  June 6, 2005

• Hokuyaku Aims at Becoming General Distributor of Healthcare Products
  June 6, 2005

• OTC Drugs Should Require Explanation at Time of Sale: Subcommittee
  June 6, 2005

• Rohto: Record-high Sales and Profits
  June 6, 2005

• Predicting Japan Pharma in 2010: Pharma Delegate Seminar
  June 6, 2005

• The Reporter's Eye: 9
  June 6, 2005

• CMIC: Strong Growth in Semiannual Sales, Profits
  June 6, 2005

• Toho Pharm.: Profits Plunge Despite 13.3% Rise in Sales
  June 6, 2005

• Wyeth's Gemtuzumab Recommended for Approval
  June 6, 2005

• Vital-Net Happy about Tie-up with Toho and Other Wholesalers
  June 6, 2005

• Alfresa HD: Profits Slip Despite Growth in Sales
  June 6, 2005

• Vfend and 8 Other Drugs Recommended for Approval
  June 6, 2005

• Suzuken Aims for Domestic Market Share of 25% by 2010
  June 6, 2005

• 18th INTERPHEX JAPAN
  June 6, 2005

• NEW PRODUCTS
  June 6, 2005

• BUSINESS NEWS IN BRIEF
  June 6, 2005

• MEDICAL DEVICE NEWS IN BRIEF
  June 6, 2005

• Zeria: Strong Consumer Health Sales Offset Drop in Ethical Sales
  June 6, 2005

• JACDS Proposes New OTC Drug-Selling Professionals
  June 6, 2005

• Fuso: Sales, Profits Up Despite Lower Sales of Kindaly
  June 6, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 462
• 463
• 464
• 465
• 466
• 467
• 468
• 469
• 470
• …
• Next ›
• 最終 »